Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010

OBJECTIVE: Therapeutic options for Parkinson's disease mainly consist of L-dopa and dopamine agonists. However, in Japan, the product labeling of the ergot dopamine agonists, cabergoline and pergolide, was revised in April 2007 due to the risk of developing cardiac valvulopathy. Here, we descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaoka, Sachiko, Ishizaki, Tatsuro, Urushihara, Hisashi, Satoh, Toshihiko, Ikeda, Shunya, Yamamoto, Mitsutoshi, Nakayama, Takeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048287/
https://www.ncbi.nlm.nih.gov/pubmed/24906013
http://dx.doi.org/10.1371/journal.pone.0099021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048287/
https://www.ncbi.nlm.nih.gov/pubmed/24906013
http://dx.doi.org/10.1371/journal.pone.0099021

Ejemplares similares